Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

The ADT tech has value and would be included in any M&A. How it gets valued depends on whether the acquirer or merged firm could commercialize it. But, as Nasrat made clear on the last CC, it retains value...

The question is our press release no longer refers to a pipeline of proprietary pharmaceutical abuse deterrent opioid products or drug products which have high barrier to entry. Does that mean those aspects of the business plan are gone for good?

No, it doesn’t. Not at all. There is an entire section about our ADT technology on our website. We still believe this is a valuable asset for Elite. We are currently focused on -- we are currently not focusing on opioids, because of the current environment around opioids in the U.S. That’s the only reason.